Literature DB >> 12637657

Pamidronate-induced tubulointerstitial nephritis with Fanconi syndrome in a patient with primary hyperparathyroidism.

Martin Buysschaert1, Jean-Pierre Cosyns, Leonel Barreto, Michel Jadoul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12637657     DOI： 10.1093/ndt/gfg044

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis.

Authors:  M Yilmaz; H Taninmis; E Kara; A Ozagari; A Unsal
Journal:  Osteoporos Int       Date:  2012-01-26       Impact factor: 4.507

2.  Nephrotic syndrome induced by pamidronate.

Authors:  M A G J ten Dam; L B Hilbrands; J F M Wetzels
Journal:  Med Oncol       Date:  2010-09-24       Impact factor: 3.064

Review 3.  Bone health issues in sarcoidosis.

Authors:  Nadera J Sweiss; Elyse E Lower; Peter Korsten; Timothy B Niewold; Murray J Favus; Robert P Baughman
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

4.  Reversible Fanconi syndrome due to lenalidomide.

Authors:  Ilya G Glezerman; Tarun Kewalramani; Kenar Jhaveri
Journal:  NDT Plus       Date:  2008-05-01

5.  Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis.

Authors:  Hong Ki Min; Eun Oh Kim; Sang Ju Lee; Yoon Kyung Chang; Kwang Sun Suh; Chul Woo Yang; Suk Young Kim; Hyeon Seok Hwang
Journal:  BMC Nephrol       Date:  2013-01-16       Impact factor: 2.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.